drug
diclofenac ER
Marketedupdated 3mo agoby IBSA Pharma Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval54 co-mentions · 20 sources
- drugdiclofenac44 co-mentions · 34 sources
- drugDICLOFENAC SODIUM19 co-mentions · 16 sources
- drugdiclofenac sodium ER19 co-mentions · 16 sources
- drugdiclofenac sodium SR19 co-mentions · 16 sources
- drugPennsaid19 co-mentions · 16 sources
- drugdiclofenac sodium DR19 co-mentions · 16 sources
- drugDictor19 co-mentions · 16 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 15 approved and 20 investigational indications.
all catalysts(1)
Trials studying diclofenac ER
- phase2ASKC200 for Knee Osteoarthritis Pain
- phase2Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis
- phase2Long Duration High Frequency Ultrasound for the Treatment of Osteoarthritis
- phase3Counterpain PXM Versus Diclofenac Versus Piroxicam
- phase3A Study to Evaluate Efficacy and Safety of AMZ001 for the Treatment of Knee Osteoarthritis Symptoms
- phase1Comparison of Diclofenac Systemic Exposure From Two Different Products (AMZ001 and Diclofenac Diethylammonium 1.16% Gel) in Healthy Participants After Repeated Topical Administrations for 7 Days.
- N/ATo Check Dermatological Safety of Test Products by 24 Hours Patch Testing
- phase1A Study of Diclofenac Gel in Women With Primary Dysmenorrhea
Patent cliff
source: FDA Orange Bookfirst barrier falls
Apr 23, 2030
~3.7 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (16)
- Feb 20, 2035method-of-use (U-3393)US 11344520
- Feb 20, 2035method-of-use (U-3393)US 11351133
- Apr 23, 2030formulationUS 86795443.7y
- Apr 23, 2030formulationUS 86795443.7y
- Apr 23, 2030method-of-use (U-55)US 89993873.7y
- Apr 23, 2030method-of-use (U-55)US 89993873.7y
- Apr 23, 2030formulationUS 90177213.7y
- Apr 23, 2030formulationUS 90177213.7y
- Apr 23, 2030formulationUS 91738543.7y
- Apr 23, 2030formulationUS 91738543.7y
- Apr 23, 2030method-of-use (U-55)US 91800953.7y
- Apr 23, 2030method-of-use (U-55)US 91800953.7y
- Apr 23, 2030formulationUS 91800963.7y
- Apr 23, 2030formulationUS 91800963.7y
- Apr 23, 2030method-of-use (U-55)US 91863283.7y
- Apr 23, 2030method-of-use (U-55)US 91863283.7y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 17m ago
Found something off?
comments(0)
5-min edit window · permanent after that